Sort
16,300 grants matching “fatty liver disease”
A Drosophila model for Alcoholic Liver Disease
$201,281Cathie M Pfleger · Icahn School Of Medicine At Mount Sinai · R21 · FY2019 · AA
Regulation of adipose tissue inflammation by the miR-181 family
$201,250Jorge Henao-Mejia · University Of Pennsylvania · R21 · FY2018 · DK
Systemic antioxidant treatment for cardiomyopathy, muscle weakness, and exercise intolerance in postmenopausal HFpEF
$201,250Leonardo Ferreira · Duke University · R21 · FY2024 · AG
Regulation of adipose tissue inflammation by the miR-181 family
$201,250Jorge Henao-Mejia · University Of Pennsylvania · R21 · FY2017 · DK
Regulation of adipose tissue inflammation by the miR-181 family
$201,250Jorge Henao-Mejia · University Of Pennsylvania · R21 · FY2016 · DK
Role of Beta-Catenin in the Molecular Pathogenesis of Alcoholic Steatohepatitis
$201,135Jaideep Behari · University Of Pittsburgh At Pittsburgh · K08 · FY2009 · AA
Metabolic basis for lipid abnormality with anti-HIV tenofovir prodrugs
$200,937Bingfang Yan · University Of Cincinnati · R21 · FY2020 · AI
Aspirin and Novel Lipid Mediators in Nonalcoholic Fatty Liver Disease
$200,883Tracey Simon · Massachusetts General Hospital · K23 · FY2019 · DK
Novel single cell disease markers with a hybrid AFM scanning piezo-thermal probe
$200,791Angelo Gaitas · Kytaro, Inc. · R43 · FY2008 · GM
Oral Iron For Treating Anemia Using Nanotechnology
$200,625Ernest V Groman · Biopal, Inc · R43 · FY2013 · DK
A novel approach for reversal of autophagic defects using lysosome-targeted nanoparticles
$200,625Orian S Shirihai · University Of California Los Angeles · R21 · FY2020 · AG
Using disease-specific iPS cells to investigate fatty liver disease in a diverse human cohort
$200,625Jacquelyn J. Maher · University Of California, San Francisco · R21 · FY2019 · DK
R21: Acidic Nanoparticles for Restoration of Autophagy in Age-associated NAFLD
$200,625Mark W Grinstaff · Boston University (Charles River Campus) · R21 · FY2020 · AG
A role for glycolipids and unconventional T cell subsets in alpha-gal allergy
$200,560Onyinye I Iweala · Univ Of North Carolina Chapel Hill · K08 · FY2022 · AI
APOE4 and Loss of Synaptic Integrity
$200,536Patrick M Sullivan · Duke University · R01 · FY2008 · AG
APOE4 and Loss of Synaptic Integrity
$200,536Patrick M Sullivan · Duke University · R01 · FY2009 · AG
Mediators of fatty liver disease during HIV/SIV and cART treatment
$200,429Donald L Sodora · Seattle Biomedical Research Institute · R01 · FY2018 · AI
Etheno Adducts in Liver Cancer
$200,425Gerd P Pfeifer · Van Andel Research Institute · R21 · FY2019 · CA
A Mouse Model for Human Inherited Diseases
$200,397Philip A Wood · University Of Alabama At Birmingham · R01 · FY2008 · RR
Androgens and Nonalcoholic Steatohepatitis: The Role of Male Sex Hormones in Women with NASH
$200,382Monika Sarkar · University Of California, San Francisco · K23 · FY2017 · DK
Mechanism and structural basis of amyloid fibril formation by serum amyloid A
$200,355Wilfredo Colon · Rensselaer Polytechnic Institute · R01 · FY2011 · AG
Training Program in Molecular Metabolism
$200,250Gokhan S Hotamisligil · Harvard University D/B/A Harvard School Of Public Health · T32 · FY2025 · DK
A Chronically Implantable Microsensor Array for Monitoring Biomarkers Relevant to
$200,244Florian Solzbacher · University Of Utah · R21 · FY2008 · EB
Core C: Tissue and Imaging Core
$200,154Kevin D. O'Brien · University Of Washington · P01 · FY2017 · HL
Establishing the mechanism of benefit and dose of exercise required to improve liver histology in patients with nonalcoholic steatohepatitis
$200,135Jonathan G Stine · Pennsylvania State Univ Hershey Med Ctr · K23 · FY2025 · DK